Work

Abstract 3642: Combination nanotherapy using the PARP inhibitor talazoparib and cyclin dependent kinase inhibitor dinaciclib

Year: 2019

Type: conference-abstract

Source: Cancer Chemistry

DOI: 10.1158/1538-7445.sabcs18-3642

Authors: Paige Baldwin, Adrienne Orriols, Srinivas Sridhar

Institution: Northeastern University

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4247249153

Cites:

Cited by:

Related to: 10